| Literature DB >> 35059324 |
Siran Lin1, YuBing Peng2, Yuzhen Xu1, Wei Zhang1, Jing Wu1, Wenhong Zhang1,3,4,5, Lingyun Shao1, Yan Gao1.
Abstract
H1N1 is the most common subtype of influenza virus circulating worldwide and can cause severe disease in some populations. Early prediction and intervention for patients who develop severe influenza will greatly reduce their mortality. In this study, we conducted a comprehensive analysis of 180 PBMC samples from three published datasets from the GEO DataSets. Differentially expressed gene (DEG) analysis and weighted correlation network analysis (WGCNA) were performed to provide candidate DEGs for model building. Functional enrichment and CIBERSORT analyses were also performed to evaluate the differences in composition and function of PBMCs between patients with severe and mild disease. Finally, a risk score model was built using lasso regression analysis, with six genes (CX3CR1, KLRD1, MMP8, PRTN3, RETN and SCD) involved. The model performed moderately in the early identification of patients that develop severe H1N1 disease.Entities:
Keywords: H1N1; differentially expressed gene; prediction; risk score model; severe influenza
Mesh:
Year: 2022 PMID: 35059324 PMCID: PMC8764189 DOI: 10.3389/fcimb.2021.776840
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Flow diagram of data collection and analysis.
Figure 2Differential gene expression and functional enrichment analyses of patients with severe and mild H1N1 at an early stage in GSE111368. (A) Heatmap of differentially expressed genes (DEGs). (B) Volcano map of DEGs. Red and blue spots represent up-regulated and down-regulated genes, respectively. (C) DEGs were subjected to GO analysis in BP, CC and MF. (D) DEGs were subjected to KEGG analysis. (E) Upregulated pathways in GO-GSEA. (F) Downregulated pathways in GO-GSEA.
Figure 3Estimated immune cell fractions using CIBERSORT. (A) Relative proportion of immune infiltration in patients with severe and mild H1N1 disease. (B) Correlation matrix of all 22 immune cell proportions. (C) Box plots visualizing significantly different immune cells between patients with severe and mild H1N1 disease.
Figure 4WGCNA is applied to analyze gene modules. (A) Scale-free fit index and mean connectivity described for various soft-thresholding powers (β). (B) Color-coded co-expression modules constructed in gene dendrogram. (C) Module–trait relationships. The meaning of each row refers to the corresponding correlation and p-value. (D–F) GO analysis applied in the DEGs extracted from the midnight blue, salmon, pink, and green yellow modules.
Figure 5Predictive performance of the risk score model. (A) Predicted disease severity of the testing data in the primary cohort. (B) ROC curve analyses of the risk score model in the testing data. (C) Predicted disease severity of patients in the validation cohort. (D) ROC curve analyses of the risk score model in the validation cohort.
Figure 6Predictive performance of the model in patients with other types of influenza and the effect of bacterial coinfection and time on the model. (A) ROC curve analyses of the risk score model for patients with H3N2 from GSE61821. (B) ROC curve analyses of the risk score model for patients with influenza A virus infection from GSE101702. (C) ROC curve analyses of the risk score model with and without the parameter of bacterial coinfection at different time points. IAV, influenza A virus; T1, at enrolment; T2, approximately 48h after enrolment; T3, and >4 weeks after enrolment.